Skip to main content

LITTELFUSE INC /DE

For the period ended Dec 27, 2025. Filed Feb 19, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 19, 2026

LFUS$383.37-0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

14. Income Taxes

  1. Income Taxes

During the fiscal year ended December 27, 2025, the Company elected to prospectively adopt the guidance in ASU 2023-09. The footnote below reflects this adopted guidance for the fiscal year ended December 27, 2025. For the fiscal years ended December 28, 2024, and December 30, 2023, the footnote reflects the guidance in effect prior to the adoption of ASU 2023-09.

The 2017 Tax Cuts and Jobs Act (the "Tax Act"), among other things, imposed a one-time tax (the “Toll Charge”) on accumulated earnings of certain non-U.S. subsidiaries and included base broadening provisions commonly referred to as the global intangible low-taxed income provisions ("GILTI").

The Company elected to pay its 2017 Toll Charge over the eight-year period prescribed by the Tax Act. The eighth and final installment of the Toll Charge of $8.2 million was paid in 2025, and accordingly, there was no remaining liability on the Consolidated Balance Sheet as of December 27, 2025.

In accordance with guidance issued by the FASB staff, the Company has adopted an accounting policy to treat any GILTI inclusions as a period cost if and when incurred. Thus, for the fiscal years ended December 27, 2025, December 28, 2024, and December 30, 2023, deferred taxes were computed without consideration of the possible future impact of the GILTI provisions, and any current year impact was recorded as a part of the current portion of income tax expense.

On July 4, 2025, the United States enacted into law the legislation formally titled “An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14,” and commonly referred to as the One Big Beautiful Bill Act (“OBBB”). The OBBB contains multiple business tax provisions, including the permanent extension of several expiring provisions of the Tax Act and multiple modifications to the international tax framework. The legislation has multiple effective dates with certain provisions effective in 2025 and others to be implemented in future years, and the Company determined the impact for the year ended December 27, 2025 is not significant. The Company will continue to monitor future administrative guidance and regulations that clarify the legislative text of the OBBB and the bill’s potential effect on the Company’s income taxes.

Domestic and foreign income (loss) before income taxes is as follows:

(in thousands)202520242023
Domestic$(94,209)$3,151$40,571
Foreign97,816148,712288,027
Income before income taxes$3,607$151,863$328,598

Federal, state, and foreign income tax expense (benefit) consists of the following:

(in thousands)202520242023
Current:
Federal$3,875$(5,881)$8,188
State3,4491,8262,880
Foreign64,64458,55157,999
Subtotal$71,968$54,496$69,067
Deferred:
Federal (including State for 2024 and 2023)$1,304$4,091$1,751
State$(2,070)$—$—
Foreign4,105(6,914)(1,705)
Subtotal$3,339$(2,823)$46
Provision for income taxes$75,307$51,673$69,113

As described above, the Company elected to prospectively adopt the guidance in ASU 2023-09. In accordance with the guidance in ASU 2023-09, for the ear ended December 27, 2025, a reconciliation between income taxes computed on income before income taxes at the federal statutory rate and the provision for income taxes is provided below:

(in thousands) · 2025 · ETR%
Tax expense at statutory rate of 21%$75721.0%
Effect of Cross-Border Tax Laws:US Tax on Non-US income (GILTI)4,738131.4%
US Tax on Non-US income (Subpart F)6,760187.4%
Other(2,503)(69.4)%
Tax Credits:Foreign Tax Credits(4,301)(119.2)%
Other(1,106)(30.7)%
Nontaxable or Non-deductible items:Non-deductible goodwill impairment23,028638.4%
Non-deductible expenses3,37893.7%
Other39711.0%
Valuation Allowance40911.3%
Other1383.8%
State Taxes, Net of Federal Tax Effect (a)1,08930.2%
Foreign Tax Effects:
ChinaWithholding Taxes6,129169.9%
Other(2,895)(80.2)%
GermanyNon-U.S. income tax rate differential10,079279.4%
Non-deductible goodwill impairment17,031472.2%
Valuation allowance26,839744.1%
German Trade Tax(13,740)(380.9)%
Other(674)(18.7)%
KoreaWithholding Taxes4,752131.7%
Other61117.0%
MexicoNon-U.S. income tax rate differential (b)(4,604)(127.6)%
NetherlandsValuation allowance6,990193.8%
Other(462)(12.8)%
PhilippinesNon-U.S. income tax rate differential (c)(4,659)(129.2)%
Withholding Taxes4,712130.6%
Other2888.1%
SingaporeNon-U.S. income tax rate differential(3,906)(108.3)%
Nontaxable Income(5,100)(141.4)%
Other(346)(9.6)%
United KingdomNon-deductible goodwill impairment7,018194.6%
Other571.5%
Other Foreign Jurisdictions2306.2%
Worldwide Changes in Unrecognized Tax Benefits(5,827)(161.5)%
Provision for income taxes75,3072,087.8%

(a) In 2025, state and local income taxes in Illinois and Minnesota comprise the majority of the state and local income taxes, net of federal effect category.

(b) The Company operates certain manufacturing activities in Mexico under a Maquiladora structure. The non-U.S. income tax rate differential represents the tax benefits associated with the Maquiladora safe harbor as defined under Mexican tax law.

(c) The Company conducts certain operations in the Philippines under the Philippine Economic Zone Authority ("PEZA") regime. The non-U.S. income tax rate differential represents the preferential tax rate benefits associated with the PEZA regime as defined under Philippines tax law.

For the years 2024 and 2023, in accordance with the guidance in effect prior to ASU 2023-09, a reconciliation between income taxes computed on income before income taxes at the federal statutory rate and the provision for income taxes is provided below:

(in thousands)20242023
Tax expense at statutory rate of 21%$31,891$69,006
Non-U.S. income tax rate differential(1,130)(25,623)
Non-U.S. losses and expenses with no tax benefit9,40111,261
Tax on unremitted earnings6,6166,394
Non-deductible goodwill impairment5,810—
Net impact associated with U.S. tax on non-U.S. income, including GILTI5,8094,739
State and local taxes, net of federal tax benefit2,5331,503
Certain changes in unrecognized tax benefits and related accrued interest(8,692)(172)
Other, net(565)2,005
Provision for income taxes$51,673$69,113

Deferred income taxes are provided for the tax effects of temporary differences between the financial reporting bases and the tax bases of the Company’s assets and liabilities. Significant components of the Company’s deferred tax assets and liabilities at December 27, 2025 and December 28, 2024, were as follows:

(in thousands)20252024
Deferred tax assets:
Net operating loss carryforwards$66,851$46,263
Interest expense carryforwards47,58134,800
Accrued expenses and reserves42,15432,336
Lease liabilities16,55913,016
Excess of tax basis over the book basis for intangible assets and goodwill16,016—
Capitalized expenses11,03218,939
U.S. foreign tax credit carryforwards3,7723,490
U.S. research and other general business tax credit carryforwards1,2221,252
Other—196
Deferred tax assets205,187150,292
Less: Valuation allowance(97,557)(55,468)
Total deferred tax assets107,63094,824
Deferred tax liabilities:
Excess of book basis over the tax basis for intangible assets and goodwill134,666133,701
Excess of book basis over the tax basis for property, plant, and equipment34,44824,238
Right of use lease assets17,28912,906
Tax on unremitted earnings16,31114,612
Other1,996—
Total deferred tax liabilities204,710185,457
Net deferred tax liabilities$97,080$90,633

The deferred tax asset valuation allowance is mainly related to certain U.S. and non-U.S. net operating loss, non-U.S. interest expense carryforwards, and U.S. foreign tax credit carryforwards which are not more likely that not to be realized. The remaining U.S. and non-U.S. net operating loss, interest expense, and foreign tax credit carryforwards either have no expiration date or are expected to be utilized prior to expiration (which begin expiring in 2028). No deferred tax asset nor valuation allowance has been recorded for certain U.S. and non-U.S. net operating loss carryforwards for which the possibility of usage has been determined to be remote.

As described above, the Company has elected to prospectively adopt the guidance in ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures, or ASU 2023-09. In accordance with the guidance in ASU 2023-09, for the year ended December 27, 2025, a summary of income taxes paid net of refunds by jurisdiction is provided below:

Jurisdiction2025
Federal$10,154
State1,792
Foreign
China25,016
Singapore12,581
Philippines8,141
Mexico5,961
Korea5,853
Other$12,103
Total income taxes paid net of refunds received$81,601

State income taxes paid in Texas and Minnesota make up the majority (greater than 50%) of the total 2025 state income taxes paid. The Company paid income taxes of $88.1 million, and $81.1 million in 2024, and 2023, respectively, and received income tax refunds of $4.3 million, and $7.2 million in 2024, and 2023, respectively.

Deferred income taxes are not provided on the excess of the investment value for financial reporting over the tax basis of investments in those subsidiaries for which such excess is considered to be permanently reinvested in those operations. The Company recognized deferred tax liabilities of$16.3 million as of December 27, 2025 and$14.6 million as of December 28, 2024, related to taxes on certain non-U.S. earnings which are not considered to be permanently reinvested.

The Company has two subsidiaries in China which benefit from lower tax rates due to “tax holidays” which apply for three-year periods. The tax holiday for one of the subsidiaries expired at the end of 2023, but was later extended for an additional three years, retroactive to include all of 2024, as well as 2025 and 2026, and for the other subsidiary the tax holiday expired at the end of 2025. The Company intends to seek an extension for the expired tax holiday. Together, the tax holidays contributed $6.6 million in current tax benefits, or $0.27 per diluted share, during 2025. Future year tax benefits will depend upon the Company’s ability to obtain extensions, after the three-year periods expire. There can be no assurance that future extensions will be granted.

A reconciliation of the beginning and ending amount of unrecognized tax benefits as of December 27, 2025, December 28, 2024, and December 30, 2023 is as follows:

(in thousands)Unrecognized Tax Benefits
Balance at December 30, 2023$31,449
Additions for tax positions taken in the current year1,251
Additions for tax positions taken in the prior year375
Decreases for lapses in statute of limitations(7,650)
Other574
Balance at December 28, 2024$25,999
Additions for tax positions taken in the current year1,695
Additions for tax positions taken in the prior year170
Decreases for lapses in statute of limitations(5,850)
Decreases for settlements(563)
Other4,356
Balance at December 27, 2025$25,807

As of December 27, 2025, the net amount of tax benefits that, if recognized, would favorably affect the effective tax rate in future periods is approximately $23.2 million. None of the positions included in unrecognized tax benefits are related to tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility.

The Company recognizes accrued interest and penalties associated with uncertain tax positions as part ofincome tax expense. The Company recognized such interest benefit of $2.3 million (including a $3.5 million decrease due to a lapse in the statute of limitations), $2.7 million expense (net of a $4.1 million decrease due to a lapse in the statute of limitations) and $0.5 million expense (net of a $1.7 million decrease due to a lapse in the statute of limitations) in 2025, 2024, and 2023, respectively. Accrued interest for such matters included in Other long-term liabilities within the Consolidated Balance Sheets was $8.7 million and $11.1 million as of December 27, 2025 and December 28, 2024, respectively.

The U.S. federal statute of limitations remains open for the Company for the 2022 tax year and later years. Non-U.S. and U.S. state statutes of limitations generally range from three to seven years, although certain jurisdictions do not have a statute expiration. Tax examinations occur from time to time, including examinations currently in process in China, Germany, the Netherlands, Singapore, other non-U.S. jurisdictions and certain U.S. states. The Company does not expect to recognize a significant amount of additional tax expense as a result of concluding these examinations.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.